Brief: Aquestive Therapeutics Reports Full Year 2023 Financial Results
05/03/2024 22:12
March 5 (Reuters) - Aquestive Therapeutics Inc AQST.O :
* AQUESTIVE THERAPEUTICS REPORTS FULL YEAR 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* AQUESTIVE THERAPEUTICS INC - SEES 2024 TOTAL REVENUE $48
MILLION
TO $51 MILLION
Source text for Eikon: ID:nGNXfDTHv
Further company coverage: AQST.O
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility Of Up To $150 Million On May 12, 2026 - SEC Filing
Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income
Brief: Aquestive Therapeutics Announces Completion Of Type A Meeting With FDA For Anaphylm™ (Dibutepinephrine) Sublingual Film
Aquestive misses Q4 revenue estimates, EBITDA loss widens
Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million